Amy Robach on Factors Impacting Her Breast Cancer Treatment Decision

Video

Amy Robach, breast cancer survivor and Good Morning America news anchor, describes her diagnosis of a 2 cm tumor in her right breast that appeared isolated on ultrasound and other subsequent scans.

Amy Robach, breast cancer survivor and Good Morning America news anchor, describes her diagnosis of a 2 cm tumor in her right breast that appeared isolated on ultrasound and other subsequent scans. Despite appearing to be an easy tumor to remove via lumpectomy, Robach opted for a bilateral mastectomy. She made this decision to avoid follow-up scans, biopsies, and to provide added peace of mind.

During the mastectomy, the surgeon found a second malignant tumor that had previously not been detected. Additionally, Robach's sentinel lymph nodes were also found to be positive. After having both tumors and 13 nodes removed, her final diagnosis was stage 2, ER-positive breast cancer.

<<<

View more from the 33rd Annual Miami Breast Cancer Conference

Related Videos
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Samer A. Srour, MB ChB, MS
Rebecca L. Porter, MD, PhD